التفاصيل البيبلوغرافية
| العنوان: |
COVID-19 Precipitating Euglycaemic Diabetic Ketoacidosis with SGLT2 Inhibitor Use |
| المؤلفون: |
Jiali Fang, Matthew Genco, Rachel Caskey |
| المصدر: |
European Journal of Case Reports in Internal Medicine (2020) |
| بيانات النشر: |
SMC MEDIA SRL, 2020. |
| سنة النشر: |
2020 |
| المجموعة: |
LCC:Medicine |
| مصطلحات موضوعية: |
Medicine |
| الوصف: |
Objective: To describe a patient who developed euglycaemic diabetic ketoacidosis (DKA) in the setting of SGLT2 inhibitor use precipitated by COVID-19. Patient and methods: A 52-year-old male with type II diabetes on empagliflozin and no history of DKA presented with symptoms of COVID-19 as well as laboratory findings consistent with euglycaemic DKA. His hospital course was complicated by recurrent episodes of euglycaemic DKA as well as hyperglycaemic DKA. Conclusion: SGLT2 inhibitors should be held as early as possible in COVID-19 cases due to the risk of euglycaemic DKA. These patients should also have more intense glucose monitoring. |
| نوع الوثيقة: |
article |
| وصف الملف: |
electronic resource |
| اللغة: |
English |
| تدمد: |
2284-2594 |
| Relation: |
https://www.ejcrim.com/index.php/EJCRIM/article/view/1943; https://doaj.org/toc/2284-2594 |
| DOI: |
10.12890/2020_001943 |
| URL الوصول: |
https://doaj.org/article/12903e7b78af4b95a531d516dec7ed70 |
| رقم الانضمام: |
edsdoj.12903e7b78af4b95a531d516dec7ed70 |
| قاعدة البيانات: |
Directory of Open Access Journals |
Full Text Finder